Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Non-Current Debt (2018 - 2025)

Historic Non-Current Debt for Dna X (SONM) over the last 6 years, with Q3 2025 value amounting to $250000.0.

  • Dna X's Non-Current Debt changed N/A to $250000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $250000.0, marking a year-over-year change of. This contributed to the annual value of $66000.0 for FY2021, which is 6432.43% down from last year.
  • According to the latest figures from Q3 2025, Dna X's Non-Current Debt is $250000.0.
  • Dna X's Non-Current Debt's 5-year high stood at $566000.0 during Q1 2025, with a 5-year trough of $30000.0 in Q1 2022.
  • In the last 3 years, Dna X's Non-Current Debt had a median value of $92500.0 in 2021 and averaged $160250.0.
  • The largest annual percentage gain for Dna X's Non-Current Debt in the last 5 years was 5000.0% (2022), contrasted with its biggest fall of 7972.97% (2022).
  • Quarter analysis of 3 years shows Dna X's Non-Current Debt stood at $66000.0 in 2021, then tumbled by 43.94% to $37000.0 in 2022, then surged by 575.68% to $250000.0 in 2025.
  • Its Non-Current Debt was $250000.0 in Q3 2025, compared to $566000.0 in Q1 2025 and $37000.0 in Q3 2022.